A case of severe pityriasis rubra pilaris with a dramatic response to apremilast

Eur J Dermatol. 2018 Feb 1;28(1):128-129. doi: 10.1684/ejd.2017.3187.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Dermatologic Agents / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Phosphodiesterase 4 Inhibitors / therapeutic use*
  • Pityriasis Rubra Pilaris / drug therapy*
  • Remission Induction
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use
  • Treatment Outcome

Substances

  • Dermatologic Agents
  • Phosphodiesterase 4 Inhibitors
  • Thalidomide
  • apremilast